Never a Dull Moment: Latest and Greatest Clinical Pearls for the APN (218)

3:15 – 4:15 pm Friday, September 14

1CNE  Advanced practice providers (APP) are consistently challenged to have the most current information on diagnosis, treatment, therapy delivery strategies, adverse effects management, and nursing led research from throughout the trajectory of a disorder. The purpose of this session is to provide APP-specific education and networking related to the complexities of children diagnosed with a hematological or oncological disorder. First, a quick primer on how to read and interpret peripheral blood smears and bone marrow biopsies, which will help with initial diagnoses of hematology and liquid tumors. After an initial diagnosis is made, genomic profiling of both liquid and solid tumors is increasingly utilized to identify molecular targets. The role of the advanced practice nurse (APN) in the ordering and interpretation of these tests will be explained. Next, the intricate transition from identification of mutations to selection of mutational targets with current medications in brain tumors will be discussed. In addition, the monitoring and treatment of the complex side effect profiles will be reviewed.

Alternatively, the realm of leukemia is currently expanding to develop the new Ph-like ALL. APNs must understand this disorder as well as the current treatment strategies. As a patient transitions to bone marrow transplant (BMT), the APP should understand the current developments in the treatment of acute versus chronic graft versus host disease (GVHD) following BMT. Through each of these disorders, the APN role in the setting of the multidisciplinary clinic (MDC) is significant and can maximize patient care and coordination. MDC structure and organization by APNs will be explored. Finally, the APN should understand nursing research and how to engage in both discovery of new knowledge and dissemination of research findings. The APN is especially suited for supportive care research; ideas for potential studies will be reviewed.